As Trump shuts down USAID missions, officials warn Ebola outbreak in Uganda will spread
Some health officials in the U.S. fear the shutdown of U.S. Agency for International Development missions may have disastrous results, as the stalling of foreign aid has forced delays in what they said was the "chaotic" early U.S. response to Uganda's swelling Ebola outbreak.
The outbreak marks Uganda's eighth from an Ebola virus. The first confirmed case in the outbreak was a nurse at a hospital in the nation's capital, Kampala, who contracted Ebola on Jan. 20 or Jan. 21 and died on Jan. 29.
There are now six confirmed and six suspect cases. In two of the suspect cases, according to an internal slide shared with CBS News, health authorities have identified no epidemiological link to the other cases.
More than a dozen Americans in Uganda are also among those so far known to have been exposed to Sudan virus, the type of Ebola that had infected the initial case. Those people so far have not shown symptoms, two people familiar with the situation told CBS News.
There is no vaccine or treatment approved by the Food and Drug Administration for Sudan virus. This Ebola strain has been fatal in at least 41% of reported cases during past outbreaks, according to the World Health Organization.
The new outbreak coincides with the Trump administration's pause in foreign aid — including its response to international outbreaks that could spread. This has spawned uncertainty among health nonprofits, which now face unpaid debts and a sweeping freeze on much of their U.S. funding.
"What we're talking about are disaster relief workers, we're talking about health workers and people who are doing good and protecting America around the world," Dr. Atul Gawande, a former USAID global health director, told CBS News on Monday.
The pause has resulted in understaffed contact tracing and screening of departing international travelers in Uganda, one U.S. official said, since many experts funded by the U.S. around the region have been laid off or ordered to stop work.
USAID is set to put virtually all its staff on leave on Friday and is shutting down overseas missions.
"It puts the world at risk," said one USAID official in a message. "I'm not an alarmist, but this is very bad," the official added.
In 2022, an outbreak of Sudan virus in Uganda prompted a large American response. The U.S. ramped up screening and preparedness for the virus here and sent staff and resources to aid Uganda's efforts to contain its spread.
Uganda's healthcare system had already been stretched thin in recent months, battling a separate outbreak of a different disease – mpox – that has resulted in at least 2,031 cases, according to the WHO.
Spokespeople for the State Department and USAID did not immediately respond to a request for comment.
President Trump has also ordered the U.S. withdrawal from the WHO, which was paired with a demand for all U.S. government staff to immediately sever collaboration with the U.N. agency that is helping to coordinate the response within the country.
A U.S. health official said that CDC usually works closely with the WHO and a country's health authorities, often meeting daily to coordinate the response to outbreaks like this.
Despite the president's order regarding WHO, "CDC has been cleared to speak one-on-one with WHO counterparts related to response activities in Uganda," a CDC spokesperson said in a statement. The CDC said such conversations are also allowed regarding responses to other outbreaks of concern in Tanzania and the Democratic Republic of the Congo.
Attempts by U.S. agencies to deploy staff to aid the outbreak response have also been delayed, one official said, amid government-wide pauses to travel and spending.
While officials secured a waiver on Saturday from the State Department to free up some funds for the response, many recipients of U.S. funds have been reluctant to accept the money because of the turmoil in Washington, two people familiar with the situation said.
Nonprofits have also been grappling with a growing number of demands imposed by the Trump administration as a condition for receiving funds, like a sweeping order to purge all mentions of gender and diversity "at every level and activity, regardless of your location or the citizenship of employees or contractors" supported by U.S. dollars.
In Uganda, groups are still waiting for clarification from their in-country contacts at USAID about how the waiver would apply to their work, the people said, wary of incurring more expenses that might never be repaid.
Following Mr. Trump's executive orders, the country's health ministry urged all staff backed by CDC and USAID to "continue working in the spirit of patriotism as volunteers," in a letter obtained by CBS News, as Ugandan officials sought "to restore normalcy."
"Radio silence" from the CDC
The growing outbreak in Uganda has also left some state and local health authorities befuddled with the "radio silence" from the CDC, officials told CBS News.
In past outbreaks, CDC officials were quick to start ramping up preparedness for the possibility of cases spreading to the U.S.
External meetings and information sharing that health authorities usually rely on to communicate with CDC officials were canceled amid the communications "pause" across the Department of Health and Human Services, or HHS.
An HHS spokesperson did not immediately respond to a request for comment.
The communications pause was initially expected to end this past weekend, but many federal health officials say they're still facing delays or denials in getting approval to publish information or participate in external meetings.
"HHS continues to increase staff levels as we look forward to the new Secretary leading the agency. HHS has approved numerous communications related to critical health and safety needs and will continue to do so," Andrew Nixon, the department's communications director, told CBS News in an earlier statement.
As a stopgap, some states have been working on informal partnerships to ramp up their own preparedness for the arrival of potential cases, officials said.
The CDC was able to publish a travel alert on Wednesday about travel to Uganda, but it left out links and information from the WHO's updates about the outbreak.
Other donors stepping in
Not all health experts are alarmed about the current situation.
Two U.S. infectious disease physicians who have worked with outbreaks in the country expressed confidence that other groups and countries would be able to fill the void left by American support, but acknowledged they're concerned about the possibility of undetected spread and delays in the response.
In past outbreaks of Ebola, the U.S. has often funded many of the key steps to contain the outbreak in its earliest days, including rushing to set up isolation facilities and support the outbreak response from an array of non-governmental organizations with workers in the country.
U.S.-funded laboratories have usually been on the front lines of past responses to outbreaks, through institutions like the Uganda Virus Research Institute.
Some groups, like Médecins Sans Frontières and the WHO, have tried to cover the shortfall. The WHO recently touted its launch — with the help of Canada and Europe — of a vaccination trial in response to the outbreak.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
28 minutes ago
- Newsweek
Mushroom Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hofood99 Inc. is recalling packages of their Enoki Mushrooms due to fears the product may be contaminated with listeria. Newsweek reached out to the company via phone for additional comment on Wednesday and left a voicemail. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that Listeria monocytogenes is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. Listeria could also lead to stillbirths or miscarriages in pregnant women, the FDA says. What To Know According to the FDA alert, the mushrooms were distributed nationwide to stores and retailers. The recalled mushrooms are sold in 200-gram green plastic packaging with a with UPC Barcode of 6 976532 310051 seen on the back label. No illnesses or injuries have been reported related to the recalled mushrooms. The mushrooms were distributed by Hofood99 Inc., located at 21903 56th Avenue Oakland Gardens, New York 11364. Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) What People Are Saying The FDA in the alert in part: "The contamination was discovered after samples were collected from a store in Michigan and subsequent analysis by Michigan Department of Agriculture & Rural Development (MDARD) Laboratory Division revealed the presence of Listeria monocytogenes." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued. It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled mushrooms may return the product to the original place of purchase for a full refund or destroy it, the FDA says. People with additional questions may contact the company at (917) 756-9833 weekdays from 9 a.m. to 2 p.m.
Yahoo
43 minutes ago
- Yahoo
Church hosts conference to address mental health in the Black community
MEMPHIS, Tenn. — According to the Centers for Disease Control (CDC), in 2023, suicide was the third leading cause of death among African Americans ages 15 to 34 in the U.S. Pastor Dianne Young with the Healing Center says this is why her church gathered professionals from across the country to educate people about depression and break the silence surrounding suicide in the Black community. 'We want to be able to let people talk freely about their struggles. We mention that we have them, but we don't talk about it,' said Pastor Young. Her church hosted the National Suicide and Black Church Conference at Southwest Community College. 📡 for Memphis and the Mid-South. 📧 and have the latest top stories sent right to your inbox. 'There was a theory that it didn't happen to Black people or African-Americans, but we found out it did from our own personal experiences,' she said. Executive Director of the American Psychiatric Association Foundation, Rawle Andrews Jr., says the stigma surrounding depression among Black people stems from three things: fear, shame, and discrimination. 'We were already thought to be less than human or second class, and then when I tell you I'm struggling with a mental health condition, now I'm leaning into the perception that I'm less than. I'm less than human,' said Andrews Jr. The APA says some of the common warning signs include talking or writing about death, withdrawal from friends and family, dramatic mood changes, and increased alcohol or drug use. 'If you don't see that person for a couple of days and their body language changes, get interested. Get curious,' said a workshop speaker. 'This is teaching you all to recognize, not diagnose, because when you diagnose somebody inappropriately, that can feel like a judgment or a label. Don't do that.' If you or someone you know is experiencing a crisis, experts encourage you to call the National Suicide and Crisis Lifeline at 988. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
New paper sheds light on experience of Black prisoners in infamous Stateville prison malaria experiments
Much has been said and written over the years about controversial malaria research conducted on inmates at Illinois' Stateville Penitentiary starting in the 1940s. But at least one part of that story has been largely ignored until now: the role of Black prisoners in that research, which helped lead to the modern practice of using genetic testing to understand how individual patients will react to certain medications, according to the authors of a newly published paper out of the University of Utah. 'We want to highlight the stories of Black prisoners that participated in this prison research in the 1950s onward and give them their due,' said Hannah Allen, a medical ethicist and assistant professor of philosophy at the University of Texas Rio Grande Valley, and first author of the paper, which was published as an opinion piece Wednesday in the Journal of the American Medical Association. 'They haven't been properly acknowledged in the past, and their participation in these studies was really foundational in launching the field of pharmacogenetics and, later on, precision medicine,' said Allen, who recently completed her doctorate at the University of Utah. Starting in the 1940s, researchers infected inmates at the Joliet-area prison with malaria to test the effectiveness of drugs to treat the illness as part of a U.S. military-funded effort to protect American troops overseas, according to the paper. A University of Chicago doctor was the principal investigator. The inmates consented to being part of the studies and were paid for their participation. At first, the research was greeted with enthusiasm. In 1945, Life magazine ran a spread about it, featuring a photo of a Stateville inmate with cups containing malaria-carrying mosquitoes pressed against his bare chest. The first line of the story reads, 'In three U.S. penitentiaries men who have been imprisoned as enemies of society are now helping science fight another enemy of society.' But as the years passed, attitudes began to shift. Questions arose about whether inmates could truly, freely consent to participate in medical experiments or whether they felt coerced into them because of their often dire circumstances. At the Nuremberg trials, defense attorneys for Nazi doctors introduced text and images from the Life article about Stateville prison, though an Illinois physician argued at the trials that the prisoners in Stateville consented to being part of medical research whereas Nazi prisoners did not, according to the JAMA paper. In the mid-1970s, news broke about a study at Tuskegee, in which Black men with syphilis went untreated for years — news that raised awareness of ethical problems in medical research. News outlets also began publishing more stories about prison research, according to the JAMA article. The Chicago Tribune published an article in 1973, in which an inmate participating in the Stateville malaria research said: 'I've been coerced into the project — for the money. Being here has nothing to do with 'doing good for mankind' … I didn't want to keep taking money from my family.' The experiments at Stateville came to a halt in the 1970s. A number of protections and regulations are now in place when it comes to research involving prisoners. Since the 1970s, the Stateville research has often been discussed and analyzed but little attention has been paid to its Black participants, said James Tabery, a medical ethicist and philosophy professor at the University of Utah who led the new research, which was funded by the federal National Institutes of Health. For a time, Black prisoners were excluded from the studies because of a myth that Black people were immune to malaria, Tabery said. Later on, once scientists had pinpointed the drug primaquine as an effective medication for malaria, they turned their attention to the question of why 5% to 10% of Black men experienced a violent reaction to the drug, according to the paper. Ultimately, the scientists were successful, finding that the adverse reaction was related to a specific genetic deficiency. 'There are people all over Chicago today that are getting tested, that clinicians are recommending they get a genetic test before they get prescribed a drug because they want to make sure that their patient isn't going to have an adverse reaction to the drug,' Tabery said. 'It's really sort of powerful and interesting that you can trace that approach to doing good clinical medicine right back to this particular moment and place and population.' But Tabery and Allen also found that the Black prisoners were not treated the same as the white prisoners who participated in research at Stateville. For one, they weren't paid as much as the white prisoners, the rationale being that the white prisoners were infected with malaria, whereas the Black prisoners were given the drug but not infected with the disease — though some of the Black prisoners got very ill after taking the medication, according to the paper. Also, researchers didn't protect the Black participants' privacy as well as they did for other participants. They published certain identifying information about the Black participants, such as initials, ages, heights and weights, whereas participants in the previous research were represented with case numbers, according to the paper. Researchers also recruited the Black prisoners' family members for the study, which they didn't do with earlier participants, according to the paper. 'You see them just doing things with the Black prisoners that they're not doing with the white prisoners,' Tabery said. Also, though scientists made an important discovery through the research on Black prisoners, the episode also highlights the difficulty that can occur in translating discoveries into real life help for patients. Though the World Health Organization now recommends genetic testing to protect people who are sensitive to antimalarials, many of the people who would benefit most from such testing still don't receive it because of financial barriers, supply chain issues and a lack of training, according to the paper. 'What we found is when you sort of shift to what was happening to the Black prisoners, these other lessons you hadn't thought of as being derivable from Stateville suddenly do become apparent,' Tabery said.
